EnQuest (LSE: ENQ) full-year 2025 results: Production up 5.4%, dividend raised as South East Asia pivot reshapes growth outlook
Can Southland Holdings, Inc. turn water and data center demand into a cleaner growth story? (NYSE American: SLND)
Read More 1 minute read Healthcare Industry News Sorrento Therapeutics acquires majority stake in Zhengzhou FortuneBio Sorrento Therapeutics has acquired a majority stake in Zhengzhou Fortune Bioscience (Zhengzhou FortuneBio), a Chinese diagnostic manufacturer, for… byPallavi MadhirajuFebruary 20, 2022
